Developing a new method for faster DNA sequencing without enzymes
Enzymeless, controlled electrostatic ratcheting in solid-state nanopores
['FUNDING_R01'] · COLUMBIA UNIV NEW YORK MORNINGSIDE · NIH-11146064
This study is working on a new way to read DNA that doesn't rely on enzymes, making it faster and more accurate, which could help doctors get important genetic information more easily and affordably.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | COLUMBIA UNIV NEW YORK MORNINGSIDE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11146064 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a novel DNA sequencing technology that operates without the need for enzymes, using controlled electrostatic forces in solid-state nanopores. The approach aims to achieve faster sequencing speeds and improved accuracy by eliminating the limitations associated with traditional enzyme-based methods. By optimizing the conditions within the nanopores, the researchers hope to enhance the detection of DNA sequences in real-time, making the process more efficient and cost-effective for clinical applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals requiring advanced genetic testing for conditions such as hereditary diseases or cancer.
Not a fit: Patients who do not require DNA sequencing or have conditions that are not related to genetic factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significantly faster and more accurate DNA sequencing, benefiting patients through improved diagnostics and personalized medicine.
How similar studies have performed: While there have been advancements in DNA sequencing technologies, this specific approach of enzymeless sequencing in solid-state nanopores is relatively novel and has not been extensively tested.
Where this research is happening
NEW YORK, UNITED STATES
- COLUMBIA UNIV NEW YORK MORNINGSIDE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHEPARD, KENNETH L — COLUMBIA UNIV NEW YORK MORNINGSIDE
- Study coordinator: SHEPARD, KENNETH L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.